United States · 
Who invested in Adaptive Phage Therapeutics?
Adaptive Phage Therapeutics's investors include LD Capital, Deerfield, Alexandria Venture Investments and Mayo Clinic.
United States · Series B startup
Who invested in Adaptive Phage Therapeutics
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $12MJun 2023
- Investors
- 4
The rounds
- Jun 2023Series B$12M
Source recordedSEC filing: $12M sold, first sale May 2023
Founders and team
From the SEC filings it signed: 3 on the team.
- Gregory L. MerrilExecutive Officer, Director, Promoteri
- Michael L. OrndorffExecutive Officeri
- Subhendu L. BasuExecutive Officeri
On the board, as filediCarl R. MerrilEvan L. LohIan L. HardyJana L. JensenJesse L. GoodmanJonathan L. LeffMartin L. HeideckerRaymond L. Martz
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Adaptive Phage Therapeutics
How much has Adaptive Phage Therapeutics raised?
Adaptive Phage Therapeutics has raised $12M across 1 round since 2023.
When did Adaptive Phage Therapeutics last raise?
Adaptive Phage Therapeutics's most recent round was a Series B of $12M in Jun 2023.
What was Adaptive Phage Therapeutics's biggest round?
Its most recent round, $12M in Jun 2023, is also its largest on record.
Who backed Adaptive Phage Therapeutics first?
Adaptive Phage Therapeutics's first round on record, in Jun 2023, was backed by LD Capital, Deerfield and Alexandria Venture Investments and 1 others.
What stage is Adaptive Phage Therapeutics at?
Adaptive Phage Therapeutics's latest named round is a Series B, in Jun 2023.
Where is Adaptive Phage Therapeutics based?
Adaptive Phage Therapeutics is based in the United States.
Companies like Adaptive Phage Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.